ACE inhibitors in hypertension: Still a shortage of evidence

Collins R. , Peto R. Antihypertensive drug therapy: Effects on Stroke and Coronary Heart Disease . In: Textbook of Hypertension Blackwell Scientific Publications 1994, UK. p1156-1164.

Nayler WG Review of Preclinical Data of Calcium Channel Blockers and Atherosclerosis . J Cardiovasc Pharmacol 1999; 33 (Suppl 2): S7-11.1.

Opie L. Angiotensin-Converting Enzyme Inhibitors: The Advances Continue. NewYork:Authors' Publishing House, 1999.

World Health Organisation - International Society of Hypertension Blood Pressure Lowering Treatment Triallists ' Collaboration. Protocol for prospective collaborative overviews of major trials of blood-pressure-lowering treatments. J Hypertens 1998;16:127-137.

Hansson L. , Lindholm LH , Niskanen L. et al., for the CAPPP Study Group , Principal results of the Captopril Prevention Project (CAPPP) randomised trial . Lancet 1999;353:611-16.

Hansson L. , Lindholm LH , Ekborn T. , et al., for the STOP-Hypertension 2 study group. Lancet 1999;354:1751-6.

Davis BR , Cutler JA , Gordon DJ et al., for the ALLHAT Research Group. Rationale and design for the Antihypertensive and Lipid Lowering treatment to prevent Heart Attack Trial (ALLHAT). Am J Hypertens 1996;9:342-60.

The Anglo Scandinavian Cardiac Outcomes Trial (ASCOT). Dahlof B. , Sever PS , Poulter NR , Wedel H. on behalf of the ASCOT Steering Committee. Imperial College School of Medicine, London, UK. Abstract. AMJ 1998:11A-10A.

Wood D. , Durrington P. , Poulter N. , McInnes G. , Rees A. , Wray R. for the British Cardiac Society, British Hyperlipidaemia Association, British Hypertension Society, and British Diabetic Association. Joint British recommendations on prevention of coronary heart disease in clinical practice. Heart 1998;80:S1-S29.